Corneal samples were homogenized as described by Brown et
al.
20 After homogenization in 200 μl Tris-HCl, pH 7.4
(50 mM), containing 10 mM CaCl
2 and 1% Triton
X-100, the samples were centrifuged at 9000
g at 4°C for 30
minutes. The concentrations of the total protein were measured with the
BCA protein assay. Equal amounts of individual samples (5 μg) were
mixed with 5 μl of 4× sample loading buffer (0.125 M Tris-HCl, pH
6.8, 4% SDS, 40% glycerol, and 0.02% bromphenol blue) containingβ
-mercaptoethanol and boiled for 5 minutes. The samples and a
prestained molecular weight marker (Bio-Rad, Cambridge, MA) were
electrophoresed on 12% SDS gels and subsequently transferred to
nitrocellulose membranes. The membranes were blocked for 30 minutes in
Blotto (TBS containing 0.5% Tween 20, 3% nonfat milk, and 2% bovine
serum albumin) and then incubated with the specific primary antibodies
that included a monoclonal anti-human MT1-MMP antibody (IM 57L, 4μ
g/ml; Oncogene, Manhasset, NY), a monoclonal anti-human MT2-MMP
antibody (IM 48L, 4 μg/ml; Oncogene), and a polyclonal anti-human
MT3-MMP antibody (AB 853, 4 μg/ml; Chemicon, Temecula, CA),
respectively, on a rocker at room temperature for 2 hours. These
antibodies also recognize the respective mouse MT1-MMP, MT2-MMP, and
MT3-MMP. Samples without primary antibody treatment were processed as
negative controls. Afterward, the blots were incubated with secondary
antibodies conjugated with horseradish peroxidase (0.5 μg/ml;
Boehringer Mannheim, Indianapolis, IN) at room temperature for 1 hour.
Finally, the blots were developed by chemiluminescence kit (Amersham,
Arlington Heights, IL) and MT1-MMP, MT2-MMP, and MT3-MMP were
visualized as dark bands with molecular weights of 65, 72, and 64 kDa,
respectively.